Bioactive substances produced by Burkholderia sp. with antifungal action in Candida spp
Abstract
Yeasts of the genus Candida are commensals, colonizing the gastrointestinal and genital tract. Accounting for 15% of hospital acquired infections, they are considered a pathogen of clinical importance. The emergence of fungal infections and the occurrence of intrinsic and acquired resistance have reflected in the increased search for new antimicrobials. The objective of this study was to evaluate the antifungal activity of extracellular substances produced by Burkholderia sp. strain RV7S3, for yeast control of the genus Candida. The substance responsible for the antifungal activity was identified and characterized biochemically, its activity was evaluated by agar diffusion tests, minimum inhibitory concentration (MIC), action effect on biofilm formation, and hemolytic activity. The data suggested that the antifungal substance is a hydrolase that exhibits lipolytic activity. The lowest concentration of this enzyme, capable of inhibiting 90% of fungal growth, was 0.38 µg.mL-1. The agar diffusion test showed inhibition halo formation of fungal growth with a diameter of 10 mm or greater, presenting 17.5 ± 0.5 mm. The substance showed low hemolytic activity and reduced biofilm cell viability, demonstrating its potential as an antifungal agent.Downloads
References
Blum H, Beier H and Gross HJ (1987) Improved silver staining of plants, RNA and DNA in polyacrylamide gels. Electrophoresis 8: 93-99.
Bohach GA, Cavalieri SJ and Snyder IS (1988) Purification of Escherichia coli alpha-hemolysin. Methods in Enzymology 165: 137-146.
Bradford MM (1976) A rapid method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry 72: 248-254.
Braine T (2011) Race against time to develop new antibiotics. Bulletin of the World Health Organization 89:88-89. http://www.who.int. Accessed 2 Nov. 2016.
Cain CC, Henry AT, Waldo RH, Casida JR LJ and Falkinham JO (2000) Identification and characteristics of a novel Burkholderia strain with broadspectrum antimicrobial activity. Applied and Environmental Microbiology 66: 4139-4141.
Castro HF, Mendes AA and Santos JC (2004) Modificações de óleos e gorduras por biotransformação. Química Nova 27: 146-156.
Castro-Ochoa LD, Rodriguez-Gomes C, Valerio-Alfaro G and Ros RO (2005) Screening, purification and -characterization of the thermoalkalophilic lipase produced by Bacillus thermoleovorans CCR11. Enzyme and microbial Technology 37: 648-654.
Chia-Feng L, Chi-Yang Y, I-Ching K and Shiow-Ling L (2012) Optimization of Lipase Production by Burkholderia sp. Using Response Surface Methodology. International Journal of Molecular Sciences 13: 14889-14897.
França JC, Ribeiro CE and Queiroz-Telles F (2008) Candidemia em um Hospital terciário brasileiro: incidência, frequência das diferentes espécies, fatores de risco e suscetibilidade aos antifúngicos. Revista da Sociedade Brasileira de Medicina Tropical 41: 23-28.
Godoy P, Tiraboschi IN, Severo LC, Bustamante B, Calvo B, Almeida LP, Matta DA and Colombo AL (2003) Species Dsitribution and Antifungal Susceptibility Profile of Candida spp. Bloodstream Isolates from Latin American Hospitals. Memórias do Instituto Oswaldo Cruz 98: 401-405.
Gupta R, Gupta N and Rathi P (2004) Bacterial lipases: an overview of production, purification and biochemical properties. Applied Microbiology and Biotechnology 64: 763-781.
Laemmli UK (1970) Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature: international journal of science 227: 680-685.
Messias JM, Costa BZ, Lima VMG, Giese EC, Dekker RFH and Barbosa AM (2011) Microbial lipases: Production, properties and biotechnological applications. Ciências Exatas e Tecnológicas 32: 213-234.
Mossialos E, Morel CM, Edwards S, Berenson J, Gemmill-Toyama M and Brogan D (2010) Policies and incentives for promoting innovation in antibiotic research. WHO, Geneva, 195p.
Nascimento GGF, Locatelli J, Freitas PCD and Paulo C (2000) Atividade de extratos vegetais e fitofármacos sobre bactérias resistentes a antibióticos. Brazilian Journal of Microbiology 31: 247-256.
Oliveira AG, Murate LS, Spago FR, Lopes LP, Beranger JPO, San Martin JAB, Nogueira MA, Mello JCP, Andrade CGTJ and Andrade G (2011) Evaluation of the antibiotic activity of extracellular compounds produced by the Pseudomonas strain against the Xanthomonas citri pv. citri 306 strain. Biological Control 56: 125-131.
Padilha GS, Alegre RM and Tambourgi EB (2010) Partição da lipase de Burkholderia cepacia em sistema bifásico aquoso PEG 4000/fosfato. Exacta 8: 193-199.
Pfaller MA, Andes DR, Diekeman DJ, Horn DL, Reboli AC, Rotstein C, Franks B and Azie NE (2014) Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2.496 patients: Data from the prospective antifungal therapy (PATH) registry 2004-2008. PLoS One 9: 1-12.
Rodrigues D, Mezzari A and Fuentefria AM (2011) Candidúria: Revisão Atual. Revista Brasileira em Promoção da Saúde 24: 142-150.
Shu Z, Lin R, Jiang H, Zhang Y, Wang M and Huang J (2009) A rapid and efficient method for directed screening of lipase production Burkholderia cepacia complex strains with organic solvent tolerance from rhizosphere. Journal of Bioscence and Bioengineering 107: 658-661.
Silva SMFQ, Pinheiro SMB, Queiroz MVF, Pranchevivius MC, Castro JGD, Perim MC and Carreiro SC (2012) In vitro activity of crude extracts of two plant species in the Cerrado on yeast of the Candida spp variety. Ciência e Saúde Coletiva 17: 1649-1656.
Spadari CDC (2013) Bioprospecção de uma substância antifúngica potencialmente nova produzida por actinomicetos isolados no RS. Dissertation, Universidade Federal do Rio Grande do Sul.
Zhang L and Xu Z (2008) Assessing Bacterial diversity in soil. Journal of Soils and Sediments 8:379-388.
doi.org/10.33158/ASB